×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Ch... [18]
THE STATE KEY LA... [6]
Faculty of Healt... [5]
INSTITUTE OF APP... [1]
Authors
LEUNG CHUNG HANG [5]
LU JINJIAN [3]
CHEN XIUPING [3]
YU HUA [2]
WANG YING [2]
WANG YITAO [1]
More...
Document Type
Journal article [21]
Patent [1]
Date Issued
2024 [3]
2023 [5]
2022 [2]
2018 [2]
2017 [4]
2016 [2]
More...
Language
英語English [19]
Source Publication
Cancer Letters [2]
Molecules [2]
ACTA PHARMACOLOG... [1]
American Journal... [1]
BIOORGANIC & MED... [1]
Biochemical Phar... [1]
More...
Indexed By
SCIE [18]
IC [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 22
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy
Journal article
Mo, Hualong, Liu, Jie Ying, Su, Zhengxi, Zhao, Deng Gao, Ma, Yan Yan, Zhang, Kun, Wang, Qi, Fu, Chun, Wang, Yao, Chen, Meiwan, Hu, Burong. Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy[J]. European Journal of Medicinal Chemistry, 2024, 277, 116765.
Authors:
Mo, Hualong
;
Liu, Jie Ying
;
Su, Zhengxi
;
Zhao, Deng Gao
;
Ma, Yan Yan
; et al.
Favorite
|
TC[WOS]:
1
TC[Scopus]:
1
IF:
6.0
/
6.1
|
Submit date:2024/09/03
Antitumor
Hdac
Isoalantolactone
Self-assembled Nanoparticles
Stat3
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma
Journal article
Zhang, Qi Yi, Ding, Wen, Mo, Jian Shan, Ou-yang, Shu Min, Lin, Zi You, Peng, Ke Ren, Liu, Guo Pin, Lu, Jin Jian, Yue, Pei Bin, Lei, Jin Ping, Wang, Yan Dong, Zhang, Xiao Lei. Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma[J]. ACTA PHARMACOLOGICA SINICA, 2024.
Authors:
Zhang, Qi Yi
;
Ding, Wen
;
Mo, Jian Shan
;
Ou-yang, Shu Min
;
Lin, Zi You
; et al.
Favorite
|
TC[WOS]:
5
TC[Scopus]:
6
IF:
6.9
/
7.6
|
Submit date:2024/05/16
Acquired Sorafenib-resistance
Antisense Oligonucleotide
Hepatocellular Carcinoma
Stat3
Ruyong formula improves thymus function of CUMS-stimulated breast cancer mice
Journal article
He, Bingqian, Guo, Wenqin, Shi, Rongzhen, Hoffman, Robert D., Luo, Qihan, Hu, Yuanjia, Guo, Jianli. Ruyong formula improves thymus function of CUMS-stimulated breast cancer mice[J]. Journal of Ethnopharmacology, 2024, 319(1), 117164.
Authors:
He, Bingqian
;
Guo, Wenqin
;
Shi, Rongzhen
;
Hoffman, Robert D.
;
Luo, Qihan
; et al.
Adobe PDF
|
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
4.8
/
4.8
|
Submit date:2024/01/02
Ruyong Formula
Breast Cancer
Epithelial Mesenchymal Transition
Cums
Thymus Function
Jak2/stat3/pi3k Pathway
Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia
Journal article
Mo, Jianshan, Deng, Lin, Peng, Keren, Ouyang, Shumin, Ding, Wen, Lou, Linlin, Lin, Ziyou, Zhu, Jianzheng, Li, Jingwei, Zhang, Qiyi, Wang, Pengyan, Wen, Yuanzhen, Chen, Xiaobing, Yue, Peibin, Lu, Jin Jian, Zhu, Kai, Zheng, Yongjiang, Wang, Yuanxiang, Zhang, Xiaolei. Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia[J]. Journal of Hematology & Oncology, 2023, 16(1), 15.
Authors:
Mo, Jianshan
;
Deng, Lin
;
Peng, Keren
;
Ouyang, Shumin
;
Ding, Wen
; et al.
Favorite
|
TC[WOS]:
15
TC[Scopus]:
14
IF:
29.5
/
26.9
|
Submit date:2023/03/06
Aml
Immunotherapy
Stat3 Inhibitor
Vista
Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells
Journal article
HE, Xinyu, FU, Jiarui, LYU, Wenyu, HUANG, Muyang, MO, Jianshan, CHENG, Yaxin, XU, Yulian, ZHENG, Lijun, ZHANG, Xiaolei, QI, Lu, ZHANG, Lele, ZHENG, Ying, HUANG, Mingqing, NI, Lin, LU, Jinjian. Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells[J]. Chinese Journal of Natural Medicines, 2023, 21(11), 842-851.
Authors:
HE, Xinyu
;
FU, Jiarui
;
LYU, Wenyu
;
HUANG, Muyang
;
MO, Jianshan
; et al.
Favorite
|
TC[WOS]:
1
TC[Scopus]:
1
IF:
4.0
/
3.7
|
Submit date:2024/01/10
Bulbocodin c
Bulbocodin d
Cancer
Erk
Natural Products
Stat3
The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone
Journal article
Shao, Zeyang, Wang, Heng, Ren, Haiyan, Sun, Yinxiang, Chen, Xiuping. The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone[J]. Molecules, 2023, 28(15).
Authors:
Shao, Zeyang
;
Wang, Heng
;
Ren, Haiyan
;
Sun, Yinxiang
;
Chen, Xiuping
Favorite
|
TC[WOS]:
12
TC[Scopus]:
10
IF:
4.2
/
4.6
|
Submit date:2024/01/10
cancer
napabucasin
NQO1
STAT3
The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone
Journal article
Zeyang Ahao, Heng Wang, Haiyan Ren, Yinxiang Sun, Xiuping Chen. The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone[J]. Molecules, 2023, 28(15), 5678.
Authors:
Zeyang Ahao
;
Heng Wang
;
Haiyan Ren
;
Yinxiang Sun
;
Xiuping Chen
Adobe PDF
|
Favorite
|
TC[WOS]:
12
TC[Scopus]:
10
IF:
4.2
/
4.6
|
Submit date:2023/08/17
Cancer
Napabucasin
Nqo1
Stat3
Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer
Journal article
Lu, Jiaye, Li, Jingwei, Lin, Ziyou, Li, Huaxuan, Lou, Linlin, Ding, Wen, Ouyang, Shumin, Wu, Yonghui, Wen, Yuanzhen, Chen, Xiaobing, Yue, Peibin, Wang, Yuanxiang, Liu, Peiqing, Lu, Jinjian, Zhang, Jian, Feng, Weineng, Zhang, Xiaolei. Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer[J]. Cancer Letters, 2023, 564, 216205.
Authors:
Lu, Jiaye
;
Li, Jingwei
;
Lin, Ziyou
;
Li, Huaxuan
;
Lou, Linlin
; et al.
Favorite
|
TC[WOS]:
25
TC[Scopus]:
25
IF:
9.1
/
8.3
|
Submit date:2023/07/20
Acquired Tki Resistance
Cd47
Lung Cancer
Stat3
Tams
Neferine Suppresses Experimental Colitis-Associated Colorectal Cancer by Inhibition of NF-KB p65 and STAT3
Journal article
Yishan Zhou, Shuangli Xiang, Haoyi Zheng, Ying Hou, Ying Wang, Chuang-Chuang Li, Qin Wu, Jingshan Shi, Xiuping Chen. Neferine Suppresses Experimental Colitis-Associated Colorectal Cancer by Inhibition of NF-KB p65 and STAT3[J]. American Journal of Chinese Medicine, 2022, 50(5), 1387-1400.
Authors:
Yishan Zhou
;
Shuangli Xiang
;
Haoyi Zheng
;
Ying Hou
;
Ying Wang
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
4
IF:
4.8
/
5.0
|
Submit date:2022/07/28
Neferine
Colitis-associated Colorectal Cancer
Nf-κb P65
Stat3
P. granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice via Suppression of NF-κB and STAT3 Pathways
Journal article
Chen, Haiming, Wang, Cheng, Tang, Bin, Yu, Jingjie, Lu, Yue, Zhang, Junhong, Yan, Yuhong, Deng, Hao, Han, Ling, Li, Shaoping, Lu, Chuanjian. P. granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice via Suppression of NF-κB and STAT3 Pathways[J]. Frontiers in Pharmacology, 2022, 12, 806844.
Authors:
Chen, Haiming
;
Wang, Cheng
;
Tang, Bin
;
Yu, Jingjie
;
Lu, Yue
; et al.
Favorite
|
TC[WOS]:
10
TC[Scopus]:
12
IF:
3.0
/
3.6
|
Submit date:2022/02/21
Anti-inflammation
Imiquimod-induced Psoriasis
Nf-κb
P. Granatum P.el P.lysaccharides
Skin Barrier
Stat3